Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease
In the absence of surrogate markers, the evaluation of suspected nonalcoholic fatty liver disease (NAFLD) is highly dependent on histological examination. The extent of sampling variability affecting the reliability of a single liver biopsy in patients with suspected NAFLD is poorly characterized. T...
Saved in:
Published in: | Hepatology (Baltimore, Md.) Vol. 44; no. 4; pp. 874 - 880 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01-10-2006
Wiley |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | In the absence of surrogate markers, the evaluation of suspected nonalcoholic fatty liver disease (NAFLD) is highly dependent on histological examination. The extent of sampling variability affecting the reliability of a single liver biopsy in patients with suspected NAFLD is poorly characterized. This prospective study aimed to correlate precise histological findings in paired biopsies—right and left lobe—in the diagnosis of NAFLD in morbidly obese subjects undergoing bariatric surgery employing both Brunt and Matteoni classifications and the NAFLD Activity Score (NAS). We also aimed to determine whether the composite histopathological findings of the two biopsies would improve diagnostic accuracy. Consecutive subjects had an intraoperative biopsy from both right and left lobes, evaluated and scored in a blinded manner. Intraobserver agreement was also assessed. Kappa coefficients of agreement were calculated. Forty‐one subjects had acceptable biopsies. Agreement for steatosis was excellent and moderate for fibrosis. Concordance was only fair for most features of necroinflammation. Intraobserver agreement was only moderate for lobular inflammation. Excellent agreement was seen for the diagnosis of NASH using Brunt criteria and good agreement when using Matteoni and NAS scoring systems. Composite biopsy data particularly improved identification of hepatocyte ballooning. The diagnostic accuracy also improved substantially when composite features were compared with single‐sided biopsy features, especially for the Matteoni and NAS scoring systems. In conclusion, significant sampling variability occurs in NAFLD, particularly for features of necroinflammation. This should be factored into the design of clinical trials and studies of the natural history of the disease. (HEPATOLOGY 2006;44:874–880.) |
---|---|
AbstractList | In the absence of surrogate markers, the evaluation of suspected nonalcoholic fatty liver disease (NAFLD) is highly dependent on histological examination. The extent of sampling variability affecting the reliability of a single liver biopsy in patients with suspected NAFLD is poorly characterized. This prospective study aimed to correlate precise histological findings in paired biopsies--right and left lobe--in the diagnosis of NAFLD in morbidly obese subjects undergoing bariatric surgery employing both Brunt and Matteoni classifications and the NAFLD Activity Score (NAS). We also aimed to determine whether the composite histopathological findings of the two biopsies would improve diagnostic accuracy. Consecutive subjects had an intraoperative biopsy from both right and left lobes, evaluated and scored in a blinded manner. Intraobserver agreement was also assessed. Kappa coefficients of agreement were calculated. Forty-one subjects had acceptable biopsies. Agreement for steatosis was excellent and moderate for fibrosis. Concordance was only fair for most features of necroinflammation. Intraobserver agreement was only moderate for lobular inflammation. Excellent agreement was seen for the diagnosis of NASH using Brunt criteria and good agreement when using Matteoni and NAS scoring systems. Composite biopsy data particularly improved identification of hepatocyte ballooning. The diagnostic accuracy also improved substantially when composite features were compared with single-sided biopsy features, especially for the Matteoni and NAS scoring systems. In conclusion, significant sampling variability occurs in NAFLD, particularly for features of necroinflammation. This should be factored into the design of clinical trials and studies of the natural history of the disease. In the absence of surrogate markers, the evaluation of suspected nonalcoholic fatty liver disease (NAFLD) is highly dependent on histological examination. The extent of sampling variability affecting the reliability of a single liver biopsy in patients with suspected NAFLD is poorly characterized. This prospective study aimed to correlate precise histological findings in paired biopsies—right and left lobe—in the diagnosis of NAFLD in morbidly obese subjects undergoing bariatric surgery employing both Brunt and Matteoni classifications and the NAFLD Activity Score (NAS). We also aimed to determine whether the composite histopathological findings of the two biopsies would improve diagnostic accuracy. Consecutive subjects had an intraoperative biopsy from both right and left lobes, evaluated and scored in a blinded manner. Intraobserver agreement was also assessed. Kappa coefficients of agreement were calculated. Forty‐one subjects had acceptable biopsies. Agreement for steatosis was excellent and moderate for fibrosis. Concordance was only fair for most features of necroinflammation. Intraobserver agreement was only moderate for lobular inflammation. Excellent agreement was seen for the diagnosis of NASH using Brunt criteria and good agreement when using Matteoni and NAS scoring systems. Composite biopsy data particularly improved identification of hepatocyte ballooning. The diagnostic accuracy also improved substantially when composite features were compared with single‐sided biopsy features, especially for the Matteoni and NAS scoring systems. In conclusion, significant sampling variability occurs in NAFLD, particularly for features of necroinflammation. This should be factored into the design of clinical trials and studies of the natural history of the disease. (HEPATOLOGY 2006;44:874–880.) |
Author | Patti, Marco G. Merriman, Raphael B. Weston, Shiobhan R. Pabst, Mark S. Aouizerat, Bradley E. Ferrell, Linda D. Bass, Nathan M. |
Author_xml | – sequence: 1 givenname: Raphael B. surname: Merriman fullname: Merriman, Raphael B. email: raphael.merriman@ucsf.edu – sequence: 2 givenname: Linda D. surname: Ferrell fullname: Ferrell, Linda D. – sequence: 3 givenname: Marco G. surname: Patti fullname: Patti, Marco G. – sequence: 4 givenname: Shiobhan R. surname: Weston fullname: Weston, Shiobhan R. – sequence: 5 givenname: Mark S. surname: Pabst fullname: Pabst, Mark S. – sequence: 6 givenname: Bradley E. surname: Aouizerat fullname: Aouizerat, Bradley E. – sequence: 7 givenname: Nathan M. surname: Bass fullname: Bass, Nathan M. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18178906$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/17006934$$D View this record in MEDLINE/PubMed |
BookMark | eNp10EFv1DAQBWALFdFt4cAfQL6AxCHtOInX9hGtCkWqBAc4R_ZkojXyxsGTpdp_T8pG6omTL5_fG70rcTHmkYR4q-BGAdS3e5puatW02xdio3RtqqbRcCE2UBuonGrcpbhi_gUArq3tK3GpDMDWNe1G5F0uhZKfYx5lHuTkY6FepviHigwxTxyJZRzlIZcQ-3SSORDT4uZI48zyMc57yUeeCOfl43KZT5j3OUWUg5_n05rVRybP9Fq8HHxierO-1-Ln57sfu_vq4duXr7tPDxU2utlWAcCg6hXYgK1xdQiq1wgQDAXSqCySNy6gHYw3pC1aRO0wELZU675vrsWHc-5U8u8j8dwdIiOl5EfKR-621ilja73Aj2eIJTMXGrqpxIMvp05B97Rut6zb_Vt3se_W0GM4UP8s1zkX8H4FntGnofgRIz87u3Q6eAq6PbvHmOj0_8bu_u77ufovqB-V4Q |
CODEN | HPTLD9 |
CitedBy_id | crossref_primary_10_1016_S0221_0363_09_73268_8 crossref_primary_10_1148_radiol_11110156 crossref_primary_10_1016_j_jhep_2017_11_012 crossref_primary_10_1002_hep_27173 crossref_primary_10_1111_j_1572_0241_2007_01774_x crossref_primary_10_1016_S1590_8658_11_60589_6 crossref_primary_10_1097_01_rli_0000258058_44876_a5 crossref_primary_10_1111_j_1440_1746_2010_06437_x crossref_primary_10_1371_journal_pone_0238717 crossref_primary_10_1007_s15034_014_0624_4 crossref_primary_10_1259_bjr_20120653 crossref_primary_10_1053_j_gastro_2016_10_026 crossref_primary_10_1111_j_1872_034X_2012_01027_x crossref_primary_10_14218_JCTH_2021_00024 crossref_primary_10_1016_j_cgh_2021_05_059 crossref_primary_10_1097_MOG_0b013e3280b0841f crossref_primary_10_3350_cmh_2013_19_2_116 crossref_primary_10_3748_wjg_v24_i44_5005 crossref_primary_10_1371_journal_pone_0199166 crossref_primary_10_1016_S2468_1253_20_30357_5 crossref_primary_10_4254_wjh_v7_i3_575 crossref_primary_10_3748_wjg_v20_i29_10108 crossref_primary_10_1002_lt_25733 crossref_primary_10_1016_j_jceh_2021_08_002 crossref_primary_10_1007_s11695_020_04991_6 crossref_primary_10_1111_j_1440_1746_2011_06760_x crossref_primary_10_2957_kanzo_50_741 crossref_primary_10_1002_hep_22603 crossref_primary_10_1007_s12072_019_09945_4 crossref_primary_10_1111_j_1751_2980_2010_00471_x crossref_primary_10_1016_S1665_2681_19_30923_8 crossref_primary_10_1016_j_clinre_2011_10_011 crossref_primary_10_1007_s00535_021_01796_x crossref_primary_10_1111_j_1478_3231_2011_02451_x crossref_primary_10_1053_j_gastro_2020_06_006 crossref_primary_10_1007_s11892_008_0006_1 crossref_primary_10_1002_hep_21768 crossref_primary_10_1111_j_1872_034X_2011_00923_x crossref_primary_10_1007_s11695_007_9398_2 crossref_primary_10_1002_hep_22185 crossref_primary_10_1038_s41598_023_33964_9 crossref_primary_10_1002_lt_23786 crossref_primary_10_1016_j_gcb_2009_02_028 crossref_primary_10_1186_s12902_022_00980_1 crossref_primary_10_1371_journal_pone_0271572 crossref_primary_10_12659_MSM_883601 crossref_primary_10_1111_j_1872_034X_2008_00407_x crossref_primary_10_1148_radiol_2017160588 crossref_primary_10_1016_j_jhep_2010_08_023 crossref_primary_10_3238_arztebl_2014_0447 crossref_primary_10_1007_s00535_012_0581_4 crossref_primary_10_1016_j_ultrasmedbio_2012_08_010 crossref_primary_10_1111_j_1365_2036_2007_03425_x crossref_primary_10_2147_HMER_S278076 crossref_primary_10_1007_s12664_023_01339_7 crossref_primary_10_1016_j_humpath_2013_11_011 crossref_primary_10_1111_hpb_12348 crossref_primary_10_1039_C5AN01080B crossref_primary_10_1016_j_tips_2020_12_001 crossref_primary_10_1097_MEG_0b013e32832ca0cb crossref_primary_10_1016_j_cgh_2018_08_055 crossref_primary_10_1038_oby_2009_154 crossref_primary_10_1111_j_1365_2036_2008_03752_x crossref_primary_10_1002_hep_23050 crossref_primary_10_1007_s00330_019_06072_4 crossref_primary_10_1097_MEG_0000000000000919 crossref_primary_10_3892_etm_2024_12573 crossref_primary_10_1007_s00261_016_0699_6 crossref_primary_10_1002_hep_23727 crossref_primary_10_1186_1471_230X_12_2 crossref_primary_10_1111_j_1753_0407_2012_00204_x crossref_primary_10_1111_j_1365_2036_2011_04695_x crossref_primary_10_1080_00365520802555991 crossref_primary_10_1242_dmm_014472 crossref_primary_10_1007_s00261_022_03647_6 crossref_primary_10_1111_liv_13549 crossref_primary_10_3109_10408363_2011_596521 crossref_primary_10_1016_j_cld_2012_05_006 crossref_primary_10_1016_S1262_3636_08_74598_1 crossref_primary_10_1111_j_1872_034X_2010_00704_x crossref_primary_10_1016_S0973_6883_12_60103_0 crossref_primary_10_4254_wjh_v6_i5_306 crossref_primary_10_1016_j_molmet_2021_101167 crossref_primary_10_1016_j_clinre_2011_08_001 crossref_primary_10_1111_jgh_14654 crossref_primary_10_1080_17474124_2018_1415756 crossref_primary_10_1016_j_cld_2017_08_004 crossref_primary_10_1111_j_1478_3231_2010_02264_x crossref_primary_10_1007_s11695_014_1235_9 crossref_primary_10_1016_j_jhep_2008_07_035 crossref_primary_10_1016_j_ultrasmedbio_2013_02_013 crossref_primary_10_1586_egh_10_56 crossref_primary_10_1093_gastro_got006 crossref_primary_10_1016_j_ultrasmedbio_2019_03_021 crossref_primary_10_1016_j_jhep_2011_06_010 crossref_primary_10_1007_s00330_009_1330_9 crossref_primary_10_1007_s12072_022_10303_0 crossref_primary_10_1053_j_gastro_2008_08_050 crossref_primary_10_1111_j_1872_034X_2012_00976_x crossref_primary_10_1002_hep_28776 crossref_primary_10_17941_agd_799535 crossref_primary_10_1007_s00535_010_0305_6 crossref_primary_10_3350_kjhep_2009_15_2_122 crossref_primary_10_1016_j_vascn_2019_106651 crossref_primary_10_1111_j_1440_1746_2010_06612_x crossref_primary_10_3390_ijms21114189 crossref_primary_10_1016_j_ejrad_2018_08_008 crossref_primary_10_1016_j_humpath_2015_01_019 crossref_primary_10_3109_00365521_2011_634024 crossref_primary_10_1586_egh_11_97 crossref_primary_10_1016_j_mri_2011_07_028 crossref_primary_10_1097_MOL_0b013e32834c7cfc crossref_primary_10_1148_radiol_13121193 crossref_primary_10_34172_mejdd_2023_316 crossref_primary_10_1016_S0929_6646_09_60026_7 crossref_primary_10_1517_17530059_2012_691878 crossref_primary_10_1007_s00261_018_1745_3 crossref_primary_10_3390_jcm11154581 crossref_primary_10_1002_hep_30974 crossref_primary_10_1016_j_cld_2015_10_007 crossref_primary_10_2214_AJR_10_5215 crossref_primary_10_1002_jmri_25843 crossref_primary_10_1111_nyas_12016 crossref_primary_10_2214_AJR_11_6729 crossref_primary_10_1055_a_1880_2283 crossref_primary_10_4103_NJGH_NJGH_9_20 crossref_primary_10_1111_hepr_12432 crossref_primary_10_1111_j_1872_034X_2012_01106_x crossref_primary_10_1002_hep_23784 crossref_primary_10_1002_lt_23832 crossref_primary_10_1002_hep_29639 crossref_primary_10_2217_bmm_2017_0361 crossref_primary_10_1016_j_annpat_2010_10_002 crossref_primary_10_1002_hep4_1119 crossref_primary_10_4254_wjh_v2_i10_374 crossref_primary_10_1007_s00535_012_0704_y crossref_primary_10_1016_j_ultrasmedbio_2018_03_011 crossref_primary_10_1053_j_gastro_2016_03_005 crossref_primary_10_1007_s12072_022_10373_0 crossref_primary_10_3389_fphys_2022_1046497 crossref_primary_10_1016_j_jhep_2016_06_005 crossref_primary_10_1097_MEG_0000000000000671 crossref_primary_10_1111_1751_2980_12088 crossref_primary_10_1002_jmri_21837 crossref_primary_10_1111_apt_17707 crossref_primary_10_1111_j_1365_2036_2011_04740_x crossref_primary_10_1002_hep_28317 crossref_primary_10_1055_s_0040_1709491 crossref_primary_10_1016_j_hpb_2018_06_1809 crossref_primary_10_1111_j_1478_3231_2011_02482_x crossref_primary_10_1053_j_gastro_2009_04_052 crossref_primary_10_1016_j_jhep_2012_11_021 crossref_primary_10_1111_hepr_12094 crossref_primary_10_3917_heg_041_0002 crossref_primary_10_1055_a_1880_2388 crossref_primary_10_1586_17474124_2015_1049155 crossref_primary_10_14218_JCTH_2017_00009 crossref_primary_10_1002_hep_23312 crossref_primary_10_17116_terarkh201789259_65 crossref_primary_10_1038_s41374_019_0315_9 crossref_primary_10_1371_journal_pone_0277380 crossref_primary_10_1016_j_cgh_2007_06_005 crossref_primary_10_1016_j_cgh_2008_12_015 crossref_primary_10_3748_wjg_v27_i7_609 crossref_primary_10_1002_jmri_24321 crossref_primary_10_1007_s00464_020_07490_y crossref_primary_10_1007_s00261_014_0137_6 crossref_primary_10_1007_s11605_008_0704_7 crossref_primary_10_1371_journal_pone_0111551 crossref_primary_10_1007_s10620_011_1602_5 crossref_primary_10_1016_j_ejrad_2009_12_033 crossref_primary_10_1088_1361_6560_acb635 crossref_primary_10_3348_kjr_2011_12_4_403 crossref_primary_10_1016_j_gcb_2009_05_011 crossref_primary_10_1016_j_cld_2009_07_008 crossref_primary_10_1016_j_mpdhp_2008_09_005 crossref_primary_10_1055_a_2334_8525 crossref_primary_10_4254_wjh_v2_i7_275 crossref_primary_10_1007_s00261_021_02965_5 crossref_primary_10_1016_j_gcb_2009_05_009 crossref_primary_10_18525_cu_2024_9_1_1 crossref_primary_10_1016_j_jhep_2013_10_017 crossref_primary_10_1016_j_mri_2008_08_008 crossref_primary_10_1111_j_1365_2036_2010_04480_x crossref_primary_10_1371_journal_pone_0115922 crossref_primary_10_3390_curroncol29070356 crossref_primary_10_1002_hep_21711 crossref_primary_10_1111_hepr_13688 crossref_primary_10_2478_enr_2023_0013 crossref_primary_10_1097_MEG_0b013e32833f14a1 crossref_primary_10_3389_fphar_2016_00159 crossref_primary_10_3350_cmh_2021_0178 crossref_primary_10_1016_j_anndiagpath_2010_08_001 crossref_primary_10_1007_s11695_018_03638_x crossref_primary_10_4254_wjh_v9_i11_533 crossref_primary_10_1016_j_dld_2017_08_030 crossref_primary_10_1002_hep_31750 crossref_primary_10_1002_jmri_25083 crossref_primary_10_1111_jgh_16673 crossref_primary_10_3390_healthcare10020374 crossref_primary_10_3390_jcm12155072 crossref_primary_10_1016_j_ultrasmedbio_2011_12_023 crossref_primary_10_1016_j_jhep_2017_05_005 crossref_primary_10_21467_ajgr_9_1_46_58 crossref_primary_10_1111_ijpo_12947 crossref_primary_10_1016_j_ajg_2014_01_009 crossref_primary_10_1258_ar_2011_100360 crossref_primary_10_1002_hep_22137 crossref_primary_10_1016_j_gcb_2010_06_004 crossref_primary_10_1002_jmri_23928 crossref_primary_10_1111_j_1477_2574_2011_00380_x crossref_primary_10_1053_j_sempedsurg_2013_10_016 crossref_primary_10_1111_j_1600_6143_2007_02135_x crossref_primary_10_1007_s40121_022_00738_1 crossref_primary_10_1016_j_knosys_2014_11_021 crossref_primary_10_1194_jlr_R800089_JLR200 crossref_primary_10_2214_AJR_18_20012 crossref_primary_10_1007_s00330_012_2468_4 crossref_primary_10_1016_j_cld_2009_07_011 crossref_primary_10_1007_s10620_007_9992_0 crossref_primary_10_4093_jkd_2014_15_2_82 crossref_primary_10_1111_j_1651_2227_2007_00423_x crossref_primary_10_1016_j_cgh_2023_11_044 crossref_primary_10_1097_MCO_0b013e32832eb587 crossref_primary_10_1016_j_acra_2022_12_025 crossref_primary_10_1111_eci_13446 crossref_primary_10_1053_j_gastro_2022_06_073 crossref_primary_10_1016_j_clnesp_2019_10_008 crossref_primary_10_6061_clinics_2019_e1070 crossref_primary_10_1371_journal_pone_0217093 crossref_primary_10_3748_wjg_v20_i36_12956 crossref_primary_10_3917_heg_011_0002 crossref_primary_10_1186_s12876_021_01675_y |
Cites_doi | 10.1111/j.1572-0241.1999.01377.x 10.1002/hep.20012 10.1053/j.gastro.2005.03.084 10.2307/2529310 10.1056/NEJMra011775 10.1016/j.hepres.2005.09.006 10.1002/hep.20092 10.1016/j.jhep.2004.09.012 10.1016/S0270-9139(03)81112-6 10.1002/hep.20818 10.1111/j.1572-0241.2002.06038.x 10.1053/jhep.2003.50193 10.1056/NEJM200102153440706 10.1055/s-2004-823098 10.1002/hep.20701 10.1002/hep.510280206 10.1016/S1542-3565(04)00457-4 10.1016/0895-4356(93)90018-V 10.1016/S0016-5085(99)70506-8 |
ContentType | Journal Article |
Copyright | Copyright © 2006 American Association for the Study of Liver Diseases 2006 INIST-CNRS |
Copyright_xml | – notice: Copyright © 2006 American Association for the Study of Liver Diseases – notice: 2006 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1002/hep.21346 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1527-3350 |
EndPage | 880 |
ExternalDocumentID | 10_1002_hep_21346 17006934 18178906 HEP21346 |
Genre | article Comparative Study Evaluation Studies Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: American Association for the Study of Liver Diseases – fundername: National Institute of Diabetes & Digestive & Kidney Diseases funderid: DK61989; DK26743 – fundername: National Institutes of Health – fundername: American Liver Foundation – fundername: Liver Scholar Award – fundername: Schering Advanced Hepatology Fellowship Award – fundername: NIDDK NIH HHS grantid: DK61989 – fundername: NIDDK NIH HHS grantid: DK26743 |
GroupedDBID | --- --K .3N .55 .GA .GJ .Y3 05W 0R~ 10A 186 1B1 1CY 1L6 1OB 1OC 1ZS 1~5 24P 31~ 33P 3O- 3SF 3WU 4.4 4G. 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 7-5 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEDT AAESR AAEVG AAHHS AALRI AAONW AAQFI AAQQT AAQXK AASGY AAXRX AAXUO AAZKR ABCQN ABCUV ABEML ABIJN ABLJU ABMAC ABOCM ABPVW ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADMUD ADOZA ADXAS ADZMN ADZOD AECAP AEEZP AEIMD AENEX AEQDE AEUQT AFBPY AFFNX AFGKR AFPWT AFUWQ AFZJQ AHMBA AIACR AIURR AIWBW AJAOE AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BDRZF BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD F00 F01 F04 F5P FD8 FDB FEDTE FGOYB FUBAC G-S G.N GNP GODZA H.X HBH HF~ HHY HHZ HVGLF HZ~ IHE IX1 J0M J5H JPC KBYEO KQQ LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 M65 MJL MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NF~ NNB NQ- O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K R2- RGB RIG RIWAO RJQFR ROL RPZ RWI RX1 RYL SEW SSZ SUPJJ TEORI UB1 V2E V9Y W2D W8V W99 WBKPD WH7 WHWMO WIB WIH WIJ WIK WIN WJL WOHZO WQJ WRC WUP WVDHM WXI X7M XG1 XV2 ZGI ZXP ZZTAW ~IA ~WT 08R AAPBV AAUGY AAVGM ABHUG ACXME ADAWD ADDAD AFVGU AGJLS BFHJK IQODW MEWTI SAMSI WXSBR ZA5 CGR CUY CVF ECM EIF NPM AAYXX ACLDA CITATION 7X8 |
ID | FETCH-LOGICAL-c3536-b007c1d108bc4792bb1d5c00b7ebe5c18cea79bc8f7a7e58c8cc59cbec4e25dd3 |
IEDL.DBID | 33P |
ISSN | 0270-9139 |
IngestDate | Fri Oct 25 00:12:35 EDT 2024 Fri Nov 22 02:10:20 EST 2024 Sat Sep 28 07:53:55 EDT 2024 Sun Oct 29 17:07:35 EDT 2023 Sat Aug 24 01:13:20 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Human Obesity Biopsy Non alcoholic steatohepatitis Nutrition disorder Gastroenterology Pair correlation Digestive diseases Hepatic disease Nutritional status |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3536-b007c1d108bc4792bb1d5c00b7ebe5c18cea79bc8f7a7e58c8cc59cbec4e25dd3 |
Notes | fax: 415‐476‐0659 Potential conflict of interest: Nothing to report. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 17006934 |
PQID | 68917825 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_68917825 crossref_primary_10_1002_hep_21346 pubmed_primary_17006934 pascalfrancis_primary_18178906 wiley_primary_10_1002_hep_21346_HEP21346 |
PublicationCentury | 2000 |
PublicationDate | October 2006 |
PublicationDateYYYYMMDD | 2006-10-01 |
PublicationDate_xml | – month: 10 year: 2006 text: October 2006 |
PublicationDecade | 2000 |
PublicationPlace | Hoboken |
PublicationPlace_xml | – name: Hoboken – name: Hoboken, NJ – name: United States |
PublicationTitle | Hepatology (Baltimore, Md.) |
PublicationTitleAlternate | Hepatology |
PublicationYear | 2006 |
Publisher | Wiley Subscription Services, Inc., A Wiley Company Wiley |
Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley |
References | 2001; 344 1993; 46 1998; 28 2002; 97 2004; 39 2005; 128 2004; 24 2005; 41 2002; 346 2003; 37 2005; 42 2003; 38 1977; 33 2004; 2 1999; 94 1999; 116 2005; 33 1998; 11 Ratziu (R10-14-20241029) 2005; 128 Promrat (R5-14-20241029) 2004; 39 Bravo (R7-14-20241029) 2001; 344 Younossi (R20-14-20241029) 1998; 11 Brunt (R18-14-20241029) 2004; 24 Byrt (R19-14-20241029) 1993; 46 Angulo (R1-14-20241029) 2002; 346 Matteoni (R15-14-20241029) 1999; 116 Neuschwander‐Tetri (R2-14-20241029) 2003; 37 Brunt (R3-14-20241029) 2005; 33 Kleiner (R12-14-20241029) 2005; 41 Brunt (R14-14-20241029) 1999; 94 Crawford (R13-14-20241029) 1998; 28 Neuschwander‐Tetri (R4-14-20241029) 2003; 38 Lindor (R8-14-20241029) 2004; 39 Kunde (R17-14-20241029) 2005; 42 Adams (R9-14-20241029) 2005; 42 Sanyal (R6-14-20241029) 2004; 2 Landis (R16-14-20241029) 1977; 33 Mendez (R11-14-20241029) 2003; 38 Regev (R21-14-20241029) 2002; 97 |
References_xml | – volume: 37 start-page: 1202 year: 2003 end-page: 1219 article-title: Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference publication-title: HEPATOLOGY – volume: 39 start-page: 770 year: 2004 end-page: 778 article-title: Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial publication-title: HEPATOLOGY – volume: 94 start-page: 2467 year: 1999 end-page: 2474 article-title: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions publication-title: Am J Gastroenterol – volume: 24 start-page: 3 year: 2004 end-page: 20 article-title: Nonalcoholic steatohepatitis publication-title: Semin Liver Dis – volume: 2 start-page: 1107 year: 2004 end-page: 1115 article-title: A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis publication-title: Clin Gastroenterol Hepatol – volume: 128 start-page: 1898 year: 2005 end-page: 1906 article-title: Sampling variability of liver biopsy in nonalcoholic fatty liver disease publication-title: Gastroenterology – volume: 28 start-page: 323 year: 1998 end-page: 331 article-title: The normal adult human liver biopsy: a quantitative reference standard publication-title: HEPATOLOGY – volume: 11 start-page: 560 year: 1998 end-page: 565 article-title: Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations publication-title: Mod Pathol – volume: 346 start-page: 1221 year: 2002 end-page: 1231 article-title: Nonalcoholic fatty liver disease publication-title: N Engl J Med – volume: 38 start-page: 1008 year: 2003 end-page: 1017 article-title: Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR‐gamma ligand rosiglitazone publication-title: HEPATOLOGY – volume: 46 start-page: 423 year: 1993 end-page: 429 article-title: Bias, prevalence and kappa publication-title: J Clin Epidemiol – volume: 344 start-page: 495 year: 2001 end-page: 500 article-title: Liver biopsy publication-title: N Engl J Med – volume: 97 start-page: 2614 year: 2002 end-page: 2618 article-title: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection publication-title: Am J Gastroenterol – volume: 33 start-page: 68 year: 2005 end-page: 71 article-title: Pathology of nonalcoholic steatohepatitis publication-title: Hepatol Res – volume: 116 start-page: 1413 year: 1999 end-page: 1419 article-title: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity publication-title: Gastroenterology – volume: 33 start-page: 159 year: 1977 end-page: 174 article-title: The measurement of observer agreement for categorical data publication-title: Biometrics – volume: 41 start-page: 1313 year: 2005 end-page: 1321 article-title: Design and validation of a histological scoring system for nonalcoholic fatty liver disease publication-title: HEPATOLOGY – volume: 39 start-page: 188 year: 2004 end-page: 196 article-title: A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis publication-title: HEPATOLOGY – volume: 42 start-page: 650 year: 2005 end-page: 656 article-title: Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women publication-title: HEPATOLOGY – volume: 38 start-page: 673A issue: Suppl year: 2003 article-title: Sampling error and reliability of liver biopsy in patients with non‐alcoholic fatty liver disease (NAFLD) publication-title: HEPATOLOGY – volume: 42 start-page: 132 year: 2005 end-page: 138 article-title: The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies publication-title: J Hepatol – volume: 94 start-page: 2467 year: 1999 ident: R14-14-20241029 article-title: Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.1999.01377.x contributor: fullname: Brunt – volume: 39 start-page: 188 year: 2004 ident: R5-14-20241029 article-title: A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis publication-title: HEPATOLOGY doi: 10.1002/hep.20012 contributor: fullname: Promrat – volume: 128 start-page: 1898 year: 2005 ident: R10-14-20241029 article-title: Sampling variability of liver biopsy in nonalcoholic fatty liver disease publication-title: Gastroenterology doi: 10.1053/j.gastro.2005.03.084 contributor: fullname: Ratziu – volume: 33 start-page: 159 year: 1977 ident: R16-14-20241029 article-title: The measurement of observer agreement for categorical data publication-title: Biometrics doi: 10.2307/2529310 contributor: fullname: Landis – volume: 346 start-page: 1221 year: 2002 ident: R1-14-20241029 article-title: Nonalcoholic fatty liver disease publication-title: N Engl J Med doi: 10.1056/NEJMra011775 contributor: fullname: Angulo – volume: 33 start-page: 68 year: 2005 ident: R3-14-20241029 article-title: Pathology of nonalcoholic steatohepatitis publication-title: Hepatol Res doi: 10.1016/j.hepres.2005.09.006 contributor: fullname: Brunt – volume: 39 start-page: 770 year: 2004 ident: R8-14-20241029 article-title: Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial publication-title: HEPATOLOGY doi: 10.1002/hep.20092 contributor: fullname: Lindor – volume: 42 start-page: 132 year: 2005 ident: R9-14-20241029 article-title: The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies publication-title: J Hepatol doi: 10.1016/j.jhep.2004.09.012 contributor: fullname: Adams – volume: 38 start-page: 673A year: 2003 ident: R11-14-20241029 article-title: Sampling error and reliability of liver biopsy in patients with non‐alcoholic fatty liver disease (NAFLD) publication-title: HEPATOLOGY doi: 10.1016/S0270-9139(03)81112-6 contributor: fullname: Mendez – volume: 42 start-page: 650 year: 2005 ident: R17-14-20241029 article-title: Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women publication-title: HEPATOLOGY doi: 10.1002/hep.20818 contributor: fullname: Kunde – volume: 97 start-page: 2614 year: 2002 ident: R21-14-20241029 article-title: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2002.06038.x contributor: fullname: Regev – volume: 37 start-page: 1202 year: 2003 ident: R2-14-20241029 article-title: Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference publication-title: HEPATOLOGY doi: 10.1053/jhep.2003.50193 contributor: fullname: Neuschwander‐Tetri – volume: 344 start-page: 495 year: 2001 ident: R7-14-20241029 article-title: Liver biopsy publication-title: N Engl J Med doi: 10.1056/NEJM200102153440706 contributor: fullname: Bravo – volume: 38 start-page: 1008 year: 2003 ident: R4-14-20241029 article-title: Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR‐gamma ligand rosiglitazone publication-title: HEPATOLOGY contributor: fullname: Neuschwander‐Tetri – volume: 24 start-page: 3 year: 2004 ident: R18-14-20241029 article-title: Nonalcoholic steatohepatitis publication-title: Semin Liver Dis doi: 10.1055/s-2004-823098 contributor: fullname: Brunt – volume: 41 start-page: 1313 year: 2005 ident: R12-14-20241029 article-title: Design and validation of a histological scoring system for nonalcoholic fatty liver disease publication-title: HEPATOLOGY doi: 10.1002/hep.20701 contributor: fullname: Kleiner – volume: 28 start-page: 323 year: 1998 ident: R13-14-20241029 article-title: The normal adult human liver biopsy: a quantitative reference standard publication-title: HEPATOLOGY doi: 10.1002/hep.510280206 contributor: fullname: Crawford – volume: 2 start-page: 1107 year: 2004 ident: R6-14-20241029 article-title: A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis publication-title: Clin Gastroenterol Hepatol doi: 10.1016/S1542-3565(04)00457-4 contributor: fullname: Sanyal – volume: 11 start-page: 560 year: 1998 ident: R20-14-20241029 article-title: Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations publication-title: Mod Pathol contributor: fullname: Younossi – volume: 46 start-page: 423 year: 1993 ident: R19-14-20241029 article-title: Bias, prevalence and kappa publication-title: J Clin Epidemiol doi: 10.1016/0895-4356(93)90018-V contributor: fullname: Byrt – volume: 116 start-page: 1413 year: 1999 ident: R15-14-20241029 article-title: Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity publication-title: Gastroenterology doi: 10.1016/S0016-5085(99)70506-8 contributor: fullname: Matteoni |
SSID | ssj0009428 |
Score | 2.4119086 |
Snippet | In the absence of surrogate markers, the evaluation of suspected nonalcoholic fatty liver disease (NAFLD) is highly dependent on histological examination. The... |
SourceID | proquest crossref pubmed pascalfrancis wiley |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 874 |
SubjectTerms | Adult Aged Biological and medical sciences Biopsy - methods Fatty Liver - classification Fatty Liver - etiology Fatty Liver - pathology Female Gastroenterology. Liver. Pancreas. Abdomen Humans Inflammation Liver - pathology Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Metabolic diseases Middle Aged Obesity Obesity, Morbid - complications Observer Variation Other diseases. Semiology Prospective Studies |
Title | Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhep.21346 https://www.ncbi.nlm.nih.gov/pubmed/17006934 https://search.proquest.com/docview/68917825 |
Volume | 44 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFA66BxHE-6VeZhAffKlrek3xSebGXpSBCr6VJM2wMNeyrg_7956TdhsDBcG3FpKmnEtyLjnfIeSWyRCs1kDYeLjaWLNsxxL0UQtPMhVKtCkwdPEavXzwpx7C5DwsamFqfIhlwA01w-zXqOBClp0VaOinLu4RjgzhtsFLMOUb3nAFuOubvqrgdTmYXY4XqEKO21nOXDuLdgpRAllGdT-LnwzOdfvVHED9vX_9-j7ZbexO-lgLygHZ0JNDsvXcZNaPSN7FNh31xTiaj2ghYC9M6RivbVCZ5UUJLjXNJvQrn8osHc9pLnWpaYPLWlIM6NKyMpWbMHGCFr7pvpspOhKz2bz5VpMROibv_d5bd2A3zRhs5QVeiI16IsVS5nCp_Ch2pWRpoBxHRiAGgWJcaRHFUvFRJCIdcMWVCmIFIuJrN0hT74S0YGl9RihT3I9d5TDheL5IwxiMBnjFmGoQSkdZ5GbBlqSoMTeSGl3ZTYB0iSGdRdprDFuN5AyLe2HA9YKDCagM5kHEROdVmYQcfFQQUIuc1oxdzY0QudnzLXJn-Pf78smgNzQP538fekG2TQDHXAW8JK3ZtNJXZLNMq7aR3W_P-PFD |
link.rule.ids | 315,782,786,1408,27933,27934,46064,46488 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LS8QwEB50BRXE92N9BvHgpW7TZwpeRFdWfCCo4K0kaRYXdFvs7mH_vTNp12VBQfDWQtKUzEzyZSbzDcAJVxGi1lA6tLk6lLPsJArt0UhfcR0pwhTkuniKH17FVZtocs7HuTAVP8S3w40sw67XZODkkG5NWEPfTHFGfGTRLMwFESoiJXD4jxPK3cBWVsVzl0vx5WTMK-R6re-uU7vRUiFLnJhuVdHiJ8g5jWDtFnS98r-fX4XlGnqyi0pX1mDG9Ndh_r4Orm9AfkmVOqq7cSzvskLicpixd7q5wVQvL0o8VbNen33kn6qXvY9YrkxpWE3NWjLy6bJyaJM3sWOfQL4twNvTrCsHg1H9rTootAkv1-3ny45T12NwtB_6EdXqiTXPuCuUDuLEU4pnoXZdFaMmhJoLbWScKC26sYxNKLTQOkw0aklgvDDL_C1o4NBmBxjXIkg87XLp-oHMogRxA76SWzWMlKubcDyWS1pUtBtpRbDspTh1qZ26JhxOSWzSUnDK78UGR2MRpmg1FAqRfZMPyzQSeExFHW3CdiXZSd-YyJv9oAmnVoC_D5922o_2YffvTY9gofN8f5fe3Tzc7sGi9efYm4H70Bh8Ds0BzJbZ8NAq8hcF5fVr |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dSxtBEB-qQhBK1aptWqtL8cGXM7f3uUefRBMsthJQwbdjvw4DMXfkkgf_-87sXRICCkLf7mD39tiZ2f3tzM5vAE65ShC1xtKjzdWjnGUvU2iPVoaK60QRpiDXxV16-yiu-kST82uRC9PwQywdbmQZbr0mA69M0VuRhj7Z6pzoyJIN2IoQhhNxfhgOV4y7kSusiscun8LL2YJWyA96y65rm9HHStY4L0VT0OI1xLkOYN0ONNj5r3_fhU8t8GQXjabswQc7-Qydv21ofR_KS6rT0dyMY2XBKomLoWFjurfB1KisajxTs9GEPZdTNTLjF1YqW1vWErPWjDy6rJ671E3sOCGI78rvjjQr5Gz20n6rDQkdwMOgf3957bXVGDwdxmFClXpSzQ33hdJRmgVKcRNr31cp6kGsudBWppnSokhlamOhhdZxplFHIhvExoSHsIlD26_AuBZRFmifSz-MpEkyRA34Sk7VOFG-7sLPhVjyqiHdyBt65SDHqcvd1HXheE1gq5aCU3YvNjhZSDBHm6FAiJzYcl7nicBDKmpoF740gl31TYm6OYy6cObk9_bw-XV_6B6-vb_pCXSGV4P8z-_bm--w7Zw57lrgEWzOpnP7AzZqMz92avwPGpr0EQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Correlation+of+paired+liver+biopsies+in+morbidly+obese+patients+with+suspected+nonalcoholic+fatty+liver+disease&rft.jtitle=Hepatology+%28Baltimore%2C+Md.%29&rft.au=Merriman%2C+Raphael+B.&rft.au=Ferrell%2C+Linda+D.&rft.au=Patti%2C+Marco+G.&rft.au=Weston%2C+Shiobhan+R.&rft.date=2006-10-01&rft.pub=Wiley+Subscription+Services%2C+Inc.%2C+A+Wiley+Company&rft.issn=0270-9139&rft.eissn=1527-3350&rft.volume=44&rft.issue=4&rft.spage=874&rft.epage=880&rft_id=info:doi/10.1002%2Fhep.21346&rft.externalDBID=10.1002%252Fhep.21346&rft.externalDocID=HEP21346 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0270-9139&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0270-9139&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0270-9139&client=summon |